This invention relates to body fluid collection devices, particularly for the collection of whole blood. More particularly, the invention relates to fluid collection devices wherein multiple, individual samples of fluid from the same source can be withdrawn simultaneously.
U.S. Pat. No. 5,743,861 to Columbus et al. (herein incorporated by reference) discloses a cylindrical device which resembles a conventional blood collection tube. Improvements, of course, are always desired.
Improvements to the embodiments disclosed in U.S. Pat. No. 5,743,861 to Columbus et al. have been recognized. Provided is a blood collection device comprising a cartridge with a septum for interfacing with a fluid collection valve or port (i.e., blood collection needle, catheter port, blood collection set), a manifold in fluid communication with the piercing septum, a plurality of collection reservoirs in fluid communication with the manifold, each collection reservoir having additives and/or surface modifications and treatments that provide appropriate environmental conditions within the reservoir to achieve blood or sample stability for the test it is intended to be a part of. In certain embodiments, each reservoir would be designed such that a vacuum driving force would not be required to move the sample from the patient into the reservoirs.
Also disclosed is an analyzer that receives a cartridge and subsequently extracts from the cartridge from a plurality of collection reservoirs the aliquoted sample into individual sample vessels specific to the type of test (coagulation, hematology, clinical and/or immunochemistry).
Additional disclosure is directed to a blood analyzer wherein the analyzer receives a cartridge and within the analyzer is capable of performing coagulation, hematology, and clinical and/or immunochemistry analyses, especially from a single collection cartridge.
Further, a method for aliquoting biological fluids comprises the steps of: receiving a cartridge, the cartridge comprising multiple internal chambers, the content and surfaces of the chambers specific for at least two types of samples, wherein the samples are chosen from the group consisting of coagulation, hematology, immunochemistry, and clinical chemistry; and aliquoting from at least two of the chambers at least a portion of biological fluid temporarily residing in each chamber to at least one unique aliquot tube per chamber. An indicium may exist on the cartridge, wherein the indicium is interrogated by a scanning element prior to aliquoting. For example, the indicium may be a 1 dimensional or 2 dimensional bar code.
Described herein is a blood collection device for collecting and introducing in parallel, patient venous blood into a sealed multi-chambered cartridge 20, while preventing cross-contamination between the chambers. Because each chamber is isolated from the others, each chamber may contain chemical reagents or additives, which, in conventional evacuated tubes, would require separate tubes. The blood collection device of the invention allows simultaneous filing of each chamber by way of a distributor, which can be selectively placed into essentially simultaneous fluid communication with a plurality of the evacuated chambers. The blood is then able to pass from the source through the manifold and into the chambers.
The device of the invention is easy to use as it is compact and has a generally rectangular cross-sectional longitudinal shape and functions in a manner that closely resembles current blood collection technology with flexibility in fluid driving force. In particular, the blood collection device 20 is designed for use with a needle holder 10 and thus may be used when necessary or desired in conjunction with aliquot tubes or containers 240 for use with multiple test-specific analyzers (for instance, a coagulation aliquot tube or container 240a comprising citrate intended for coagulation testing; a hematology aliquot tube or container 240b comprising EDTA intended for hematology testing; or a clinical chemistry aliquot tube or container 240c comprising clot activator or enhancing surface to effect the intrinsic, extrinsic, or both intrinsic and extrinsic clotting cascades). By collecting and containing all of the desired blood samples in a single multi-chambered vessel, the number of disposables can be minimized and because multiple tubes and secondary containers may be eliminated, positive patient identification can be improved without requiring multiple container labeling for one patient sample. Furthermore, as discussed in more detail below, embodiments of the present invention employ features which may make it straightforward and inexpensive to manufacture despite the device's sophisticated capabilities.
The collection device 20 may be manufactured as components and assembled just prior to the taking of the patient sample or can be pre-assembled and ready-to-use. The device can be manufactured by utilizing any number of methods known in the art, however, the preferred method is one in which most parts are injection molded of a suitable plastic. Such plastics make the device light, unbreakable, and manufacturable at a modest cost. Furthermore, the collection device is preferably made of a biocompatible, U.S. Food and Drug Administration (FDA) approved plastic and metal components where desired that are compatible with the blood samples, chemical treatments, and analytical tests to be performed.
The overall internal cavities of each collection chamber in the blood collection device as well as the distributor aperture may be sealed, for example, with septums or self-healing seals. For instance, in a collection device 20 with multiple chambers 42, 44, and 46, septums 26, 28, and 30 respectively enable engagement between an aliquoting or extracting member 125 inserted into each chamber respectively through a seal. Such seals and septums are known in the art and allow penetration by a point, i.e., needle, such that upon withdrawal of the point, the seal substantially reseals to preclude fluid passage. Suitable materials for the seals are well known in the art and should be selected based on the intended use for the device such as biocompatibility, chemically inert, and compatible with any chemical reagents or treatments contained therein, be FDA approved, and suitable for use in automated instruments. Each aperture may be individually sealed after evacuation.
In operation, the blood collection device 20 may be used with a needle holder assembly 10 similar to that used for a conventional, evacuated blood collection tube (such as VACUTAINERâ„¢ marketed by Becton Dickinson and Company). The cartridge has a distal end 22 and a proximal end 24. After the needle is inserted into a vein, the penetrable septum 32 on the cartridge's distal end 22 is penetrated by the cannula 14 exposing the flow manifold in the cartridge to the blood source. A driving force in the chambers and manifold draws the blood through the cannula 14, the plenum/manifold, and into the respective chambers (42, 44, and 46) or reservoirs assisted by the venous pressure provided by the patient. When blood flow has ceased, the multi-chambered body/adapter unit may be removed from the needle holder assembly 10 as is the procedure with standard, evacuated collection tubes. The multi-chambered body may then be drawn away or removed completely from the adapter, allowing the self-healing septum 32 to reseal, thereby providing a plurality of chambers or reservoirs sealed with and containing blood.
As shown in
Alternatively, the extraction port (26, 28, and 30) may be employed to extract each sample of blood retained within the reservoir into a multiple test instrument, wherein the instrument extracts the sample as needed and performs the appropriate analysis by whatever sample is extracted. In this embodiment shown in
In an embodiment of the invention, the internal cavity of the cartridge may employ a vacuum or partial pressure less than that of atmospheric pressure. The driving force of this vacuum assists in the delivery of blood from a patient's blood stream upon established fluid connection between the patient's blood and the cavity. To maintain vacuum, the sidewall and septums enclosing the cavity must be resistant to vacuum loss over a reasonable period of time, such as a year. In an embodiment of the invention, a foil seal covers the septum between the internal cavity of the cartridge such that once the foil seal is broken, the pressure between the cavity and the patient's blood attempt to equalize, thereby drawing the blood sample into the cavity and individual reservoirs.
As shown in
The present invention has been described with reference to preferred embodiments. One of skill in the art will readily appreciate that changes, alterations or modifications can be made to these embodiments without departing from the true scope and spirit of the invention.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2007/003438 | 2/8/2007 | WO | 00 | 12/31/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2007/092586 | 8/16/2007 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3266298 | Whitehead et al. | Aug 1966 | A |
3482082 | Isreeli | Dec 1969 | A |
3553041 | Von Hofe | Jan 1971 | A |
3619568 | Taplin | Nov 1971 | A |
3653176 | Gess | Apr 1972 | A |
3656473 | Sodickson et al. | Apr 1972 | A |
3843440 | Davies | Oct 1974 | A |
3898433 | Sallet | Aug 1975 | A |
3985605 | Treiber et al. | Oct 1976 | A |
4292916 | Bradley et al. | Oct 1981 | A |
4589141 | Christian et al. | May 1986 | A |
4626314 | Wesley | Dec 1986 | A |
4654127 | Baker et al. | Mar 1987 | A |
4828716 | McEwen et al. | May 1989 | A |
5025798 | Schindele | Jun 1991 | A |
5119830 | Davis | Jun 1992 | A |
5143084 | Macemon et al. | Sep 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5150795 | Nakayama | Sep 1992 | A |
5220302 | Nunnally et al. | Jun 1993 | A |
5230429 | Etheredge, III | Jul 1993 | A |
5296375 | Kricka et al. | Mar 1994 | A |
5401110 | Neeley | Mar 1995 | A |
5504011 | Gavin et al. | Apr 1996 | A |
5633835 | Haas et al. | May 1997 | A |
5688361 | Itoh | Nov 1997 | A |
5743861 | Columbus et al. | Apr 1998 | A |
5971941 | Simons et al. | Oct 1999 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6319469 | Mian et al. | Nov 2001 | B1 |
6335692 | Compton | Jan 2002 | B1 |
6373786 | Kagan et al. | Apr 2002 | B1 |
6391262 | Brinton et al. | May 2002 | B1 |
6533015 | Moore | Mar 2003 | B1 |
7687031 | Yamagata et al. | Mar 2010 | B2 |
20030235119 | Wien et al. | Dec 2003 | A1 |
20040171168 | Itoh | Sep 2004 | A1 |
20040176704 | Stevens | Sep 2004 | A1 |
20040257918 | Ribi | Dec 2004 | A1 |
20050286350 | Wien | Dec 2005 | A1 |
Number | Date | Country |
---|---|---|
510615 | Apr 1992 | EP |
0486059 | May 1992 | EP |
0992287 | Apr 2000 | EP |
1004359 | May 2000 | EP |
1-156667 | Jun 1989 | JP |
3041365 | Feb 1991 | JP |
03-63570 | Mar 1991 | JP |
4-63484 | May 1992 | JP |
05-95936 | Apr 1993 | JP |
5097133 | Apr 1993 | JP |
5-71792 | Sep 1993 | JP |
6-59937 | Aug 1994 | JP |
07-167716 | Jul 1995 | JP |
9-504608 | May 1997 | JP |
9-236608 | Sep 1997 | JP |
2002-82120 | Mar 2002 | JP |
2002-102210 | Apr 2002 | JP |
2002-243734 | Aug 2002 | JP |
2003-004875 | Jan 2003 | JP |
2004-121704 | Apr 2004 | JP |
2004-347376 | Dec 2004 | JP |
0126993 | Apr 2001 | WO |
0206904 | Jan 2002 | WO |
2005116632 | Dec 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20090130646 A1 | May 2009 | US |
Number | Date | Country | |
---|---|---|---|
60771923 | Feb 2006 | US |